.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Citi
Julphar
Boehringer Ingelheim
Fuji
Farmers Insurance
Queensland Health
Chubb
Novartis
Cipla

Generated: September 26, 2017

DrugPatentWatch Database Preview

FENOFIBRIC ACID Drug Profile

« Back to Dashboard

What is the patent landscape for Fenofibric Acid, and what generic Fenofibric Acid alternatives are available?

Fenofibric Acid is a drug marketed by Alembic Pharms Ltd, Mylan Pharms Inc, Actavis Elizabeth, Lupin Ltd, Impax Labs Inc, and Anchen Pharms. and is included in six NDAs.

The generic ingredient in FENOFIBRIC ACID is choline fenofibrate. There are ninety-nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the choline fenofibrate profile page.

Summary for Tradename: FENOFIBRIC ACID

Patents:0
Applicants:6
NDAs:6
Suppliers / Packagers: see list7
Bulk Api Vendors: see list58
Clinical Trials: see list4,897
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FENOFIBRIC ACID at DailyMed

Pharmacology for Tradename: FENOFIBRIC ACID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alembic Pharms Ltd
FENOFIBRIC ACID
choline fenofibrate
CAPSULE, DELAYED RELEASE;ORAL208705-001May 12, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Ltd
FENOFIBRIC ACID
choline fenofibrate
CAPSULE, DELAYED RELEASE;ORAL200750-001Dec 4, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
FENOFIBRIC ACID
choline fenofibrate
CAPSULE, DELAYED RELEASE;ORAL200913-002Mar 25, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Anchen Pharms
FENOFIBRIC ACID
choline fenofibrate
CAPSULE, DELAYED RELEASE;ORAL201573-001Jul 18, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Ltd
FENOFIBRIC ACID
choline fenofibrate
CAPSULE, DELAYED RELEASE;ORAL200750-002Dec 4, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Alembic Pharms Ltd
FENOFIBRIC ACID
choline fenofibrate
CAPSULE, DELAYED RELEASE;ORAL208705-002May 12, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
FENOFIBRIC ACID
choline fenofibrate
CAPSULE, DELAYED RELEASE;ORAL200913-001Mar 25, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
FENOFIBRIC ACID
choline fenofibrate
CAPSULE, DELAYED RELEASE;ORAL200920-002Oct 7, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
FENOFIBRIC ACID
choline fenofibrate
CAPSULE, DELAYED RELEASE;ORAL200920-001Oct 7, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax Labs Inc
FENOFIBRIC ACID
choline fenofibrate
CAPSULE, DELAYED RELEASE;ORAL200264-002Sep 7, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
US Army
Express Scripts
Queensland Health
Moodys
US Department of Justice
McKinsey
Healthtrust
McKesson
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot